What are the most common medications involved in serotonin syndrome, including Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Monoamine Oxidase Inhibitors (MAOIs), and triptans?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Medications Involved in Serotonin Syndrome

Monoamine oxidase inhibitors (MAOIs) play a role in most cases of serotonin syndrome and pose the highest risk, especially when combined with other serotonergic medications. 1

Primary Drug Classes Associated with Serotonin Syndrome

Highest Risk Medications

  1. MAOIs

    • Highest reporting odds ratio (ROR 45.99) among all drug classes 2
    • Examples: phenelzine, isocarboxazid, moclobemide, tranylcypromine, linezolid (antibiotic with MAOI properties)
    • MAOIs should never be combined with any other serotonergic drug 1, 3
  2. Selective Serotonin Reuptake Inhibitors (SSRIs)

    • Second highest reporting odds ratio (ROR 32.66) 2
    • Examples: fluoxetine (Prozac), paroxetine (Paxil), sertraline (Zoloft), citalopram (Celexa), escitalopram (Lexapro), fluvoxamine (Luvox)
    • Most frequently reported class in adverse event databases 2
  3. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

    • Examples: venlafaxine, desvenlafaxine, duloxetine
    • Similar risk profile to SSRIs 1

Other Significant Contributors

  1. Opioid Analgesics (particularly certain types)

    • Phenylpiperidine series: pethidine (meperidine), tramadol, methadone
    • Dextromethorphan (cough suppressant)
    • These act as weak serotonin reuptake inhibitors 4
    • Note: Morphine, codeine, oxycodone, and buprenorphine do NOT precipitate serotonin syndrome with MAOIs 4
  2. Triptans

    • Examples: sumatriptan, eletriptan
    • FDA warning exists for combination with SSRIs/SNRIs, though evidence is limited 5, 6
  3. Other Medications and Substances

    • Tricyclic antidepressants
    • Tryptophan supplements (high ROR of 44.19) 2
    • St. John's Wort
    • Certain stimulants (amphetamines, methylphenidate)
    • Certain antihistamines (chlorpheniramine)
    • Illicit drugs (ecstasy, methamphetamine, cocaine, LSD) 1

High-Risk Drug Combinations

The most dangerous combinations that frequently trigger serotonin syndrome are:

  1. MAOIs + SSRIs - highest risk combination 7
  2. MAOIs + SNRIs
  3. MAOIs + Tricyclic antidepressants
  4. MAOIs + Tryptophan
  5. MAOIs + Pethidine (meperidine) 7
  6. Two or more non-MAOI serotonergic drugs in combination 1

Clinical Presentation and Diagnosis

Serotonin syndrome typically presents within 24-48 hours after starting or combining serotonergic medications with:

  • Mental status changes: confusion, agitation, anxiety
  • Neuromuscular abnormalities: tremors, clonus (most common sign, present in 57% of cases), hyperreflexia, muscle rigidity 1
  • Autonomic hyperactivity: hypertension, tachycardia, arrhythmias, tachypnea, diaphoresis, shivering, vomiting, diarrhea 1

Severe cases can progress to:

  • Fever (temperature >41.1°C)
  • Seizures
  • Arrhythmias
  • Unconsciousness
  • Death 1

Risk Factors

  • Age: Higher reporting odds ratio in adults over 65 years 2
  • Sex: Higher reporting in males 2
  • Polypharmacy: Taking multiple serotonergic medications
  • Dosage increases of serotonergic medications
  • Recent addition of a new serotonergic agent

Prevention and Management

  1. Avoid high-risk combinations - particularly MAOIs with any other serotonergic agent
  2. Observe medication-free intervals when switching between serotonergic drugs:
    • At least 2 weeks after stopping an MAOI before starting another serotonergic drug
    • At least 5 weeks after stopping fluoxetine before starting an MAOI (due to its long half-life) 3
  3. Treatment:
    • Discontinue all serotonergic agents
    • Provide supportive care with continuous cardiac monitoring
    • For severe cases: external cooling, sedation, possibly neuromuscular paralysis and intubation
    • Consider cyproheptadine (a serotonin 2A antagonist) for severe cases 1, 7

Clinicians should maintain high vigilance when prescribing any combination of serotonergic medications and report suspected cases to pharmacovigilance systems.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.